BACKGROUND: Physical activity (PA) is increasingly discussed as concomitant therapy after breast cancer diagnosis and can add to the alleviation of therapy- and disease-related symptoms. The objectives of this study were to describe PA behaviour in the course of breast cancer and to identify factors associated with change in PA. METHODS: 1,067 German postmenopausal breast cancer patients were asked about their PA behaviour before breast cancer diagnosis, during therapy and 1year after surgery. MET-hours per week (MET=metabolic equivalent) were calculated based on quantitative information about walking, bicycling for transportation purposes and sports by multiplying the average hours per week spent at each activity with an individual intensity score. Factors associated with change in MET·h/week in the course of breast cancer were identified using multiple linear regression. RESULTS: Median PA decreased significantly during therapy from 36 to 14MET·h/week (p<.001). Patients treated with chemo- and/or radiotherapy had a stronger decline in PA compared to patients without adjuvant therapy or those treated only with hormones (adjusted β=-9.73 to -13.54). The presence of medical risk factors (β=-5.56) was also associated with a decrease of PA during therapy. In contrast, participation in rehabilitation (β=7.62) was associated with an increase of PA after therapy. CONCLUSION: In the light of the drastic decline in PA during therapy, programs promoting PA seem obligatory for all breast cancer patients. Patients treated with chemo- and/or radiotherapy and those with medical risk factors should particularly be assisted in reaching recommended activity levels by targeted interventions during and after therapy.
BACKGROUND: Physical activity (PA) is increasingly discussed as concomitant therapy after breast cancer diagnosis and can add to the alleviation of therapy- and disease-related symptoms. The objectives of this study were to describe PA behaviour in the course of breast cancer and to identify factors associated with change in PA. METHODS: 1,067 German postmenopausal breast cancerpatients were asked about their PA behaviour before breast cancer diagnosis, during therapy and 1year after surgery. MET-hours per week (MET=metabolic equivalent) were calculated based on quantitative information about walking, bicycling for transportation purposes and sports by multiplying the average hours per week spent at each activity with an individual intensity score. Factors associated with change in MET·h/week in the course of breast cancer were identified using multiple linear regression. RESULTS: Median PA decreased significantly during therapy from 36 to 14MET·h/week (p<.001). Patients treated with chemo- and/or radiotherapy had a stronger decline in PA compared to patients without adjuvant therapy or those treated only with hormones (adjusted β=-9.73 to -13.54). The presence of medical risk factors (β=-5.56) was also associated with a decrease of PA during therapy. In contrast, participation in rehabilitation (β=7.62) was associated with an increase of PA after therapy. CONCLUSION: In the light of the drastic decline in PA during therapy, programs promoting PA seem obligatory for all breast cancerpatients. Patients treated with chemo- and/or radiotherapy and those with medical risk factors should particularly be assisted in reaching recommended activity levels by targeted interventions during and after therapy.
Authors: Anne M Nielsen; Whitney A Welch; Kara L Gavin; Alison M Cottrell; Payton Solk; Emily A Torre; Danielle Blanch-Hartigan; Siobhan M Phillips Journal: Support Care Cancer Date: 2019-07-31 Impact factor: 3.603
Authors: F Hausmann; V V Iversen; M Kristoffersen; H Gundersen; E Johannsson; M Vika Journal: Support Care Cancer Date: 2018-04-14 Impact factor: 3.603
Authors: Lawson Eng; Dan Pringle; Jie Su; XiaoWei Shen; Mary Mahler; Chongya Niu; Rebecca Charow; Kyoko Tiessen; Christine Lam; Oleksandr Halytskyy; Hiten Naik; Henrique Hon; Margaret Irwin; Vivien Pat; Christina Gonos; Catherine Chan; Jodie Villeneuve; Luke Harland; Ravi M Shani; M Catherine Brown; Peter Selby; Doris Howell; Wei Xu; Geoffrey Liu; Shabbir M H Alibhai; Jennifer M Jones Journal: Support Care Cancer Date: 2018-05-29 Impact factor: 3.603
Authors: Si-Woon Park; Ilkyun Lee; Joong Il Kim; Hyuna Park; Jong Doo Lee; Kyeong Eun Uhm; Ji Hye Hwang; Eun Sook Lee; So-Youn Jung; Yong Hyun Park; Ji Youl Lee Journal: Support Care Cancer Date: 2018-08-25 Impact factor: 3.603
Authors: Freerk T Baumann; Oliver Bieck; Max Oberste; Rafaela Kuhn; Joachim Schmitt; Steffen Wentrock; Eva Zopf; Wilhelm Bloch; Klaus Schüle; Monika Reuss-Borst Journal: Support Care Cancer Date: 2016-12-09 Impact factor: 3.603
Authors: A-M Foucaut; S E Berthouze-Aranda; M Touillaud; A-S Kempf-Lépine; C Baudinet; R Meyrand; J Carretier; P Bachmann; B Fervers Journal: Support Care Cancer Date: 2013-12-03 Impact factor: 3.603
Authors: Marloes G M Derks; Nienke A de Glas; Esther Bastiaannet; Anton J M de Craen; Johanneke E A Portielje; Cornelis J H van de Velde; Floor E van Leeuwen; Gerrit-Jan Liefers Journal: Oncologist Date: 2016-07-01